Long-term treatment with interferon alfa for myeloproliferative neoplasms

被引：9
|
作者：
Kiladjian, Jean-Jacques [1 ,2 ]
机构：
[1] Univ Paris Diderot, Hop St Louis, AP HP, INSERM CIC 1427, Paris, France
[2] Hop St Louis, Ctr Invest Clin, F-75010 Paris, France
来源：
LANCET HAEMATOLOGY | 2017年 / 4卷 / 04期
关键词：
ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; HYDROXYUREA; ANAGRELIDE; TRIAL;
D O I：
10.1016/S2352-3026(17)30039-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E150 / E151
页数：2
相关论文
共 50 条
  • [1] Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature
    How, Joan
    Hobbs, Gabriela
    CANCERS, 2020, 12 (07) : 1 - 13
  • [2] Interferon Alfa in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Hasselbalch, Hans Carl
    Kiladjian, Jean-Jacques
    Silver, Richard T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : E564 - E565
  • [3] Interferon alfa: Effects of long-term treatment for polycythemia vera
    Silver, RT
    SEMINARS IN HEMATOLOGY, 1997, 34 (01) : 40 - 50
  • [4] The myeloproliferative disorders and their treatment with interferon alfa
    Silver, RT
    MOLECULAR BIOLOGY OF HEMATOPOIESIS 5, 1996, : 571 - 576
  • [5] LONG-TERM INTERFERON THERAPY FOR THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISEASES
    GISSLINGER, H
    LUDWIG, H
    LINKESCH, W
    CHOTT, A
    FRITZ, E
    RADASZKIEWICZ, T
    LANCET, 1989, 1 (8639): : 634 - 637
  • [6] Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment
    Kjaer, Lasse
    Cordua, Sabrina
    Holmstrom, Morten O.
    Thomassen, Mads
    Kruse, Torben A.
    Pallisgaard, Niels
    Larsen, Thomas S.
    de Stricker, Karin
    Skov, Vibe
    Hasselbalch, Hans C.
    PLOS ONE, 2016, 11 (10):
  • [7] Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms
    A. Yacoub
    O. Odenike
    S. Verstovsek
    Current Hematologic Malignancy Reports, 2014, 9 : 350 - 359
  • [8] Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms
    Yacoub, A.
    Odenike, O.
    Verstovsek, S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (04) : 350 - 359
  • [9] PSYCHIATRIC COMPLICATIONS OF LONG-TERM INTERFERON ALFA THERAPY
    RENAULT, PF
    HOOFNAGLE, JH
    PARK, Y
    MULLEN, KD
    PETERS, M
    JONES, B
    RUSTGI, V
    JONES, A
    ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (09) : 1577 - 1580
  • [10] The role of alfa interferon (IFN) in treating chronic myeloproliferative disease (MPD): Indications and results of long-term management
    Gilbert, H
    BLOOD, 1995, 86 (10) : 178 - 178
12345